IDEXX Laboratories (IDXX) Competitors

Envista (NYSE:NVST) and IDEXX Laboratories (NASDAQ:IDXX) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, media sentiment, dividends, earnings and analyst recommendations.

Is NVST or IDXX more profitable?

IDEXX Laboratories has a net margin of 24.41% compared to Envista's net margin of 2.11%. IDEXX Laboratories' return on equity of 64.42% beat Envista's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Envista	2.11%	4.84%	2.68%
IDEXX Laboratories	24.41%	64.42%	29.89%

Do analysts prefer NVST or IDXX?

Envista presently has a consensus price target of $21.08, suggesting a potential upside of 10.35%. IDEXX Laboratories has a consensus price target of $656.50, suggesting a potential upside of 6.55%. Given Envista's higher possible upside, equities analysts plainly believe Envista is more favorable than IDEXX Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envista	2 Sell rating(s)	10 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.24
IDEXX Laboratories	0 Sell rating(s)	4 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.75

Do insiders & institutionals hold more shares of NVST or IDXX?

87.8% of IDEXX Laboratories shares are owned by institutional investors. 0.7% of Envista shares are owned by insiders. Comparatively, 1.0% of IDEXX Laboratories shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Does the media refer more to NVST or IDXX?

In the previous week, IDEXX Laboratories had 22 more articles in the media than Envista. MarketBeat recorded 28 mentions for IDEXX Laboratories and 6 mentions for Envista. IDEXX Laboratories' average media sentiment score of 1.35 beat Envista's score of 0.20 indicating that IDEXX Laboratories is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Envista	0 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
IDEXX Laboratories	20 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has better earnings and valuation, NVST or IDXX?

IDEXX Laboratories has higher revenue and earnings than Envista. IDEXX Laboratories is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envista	$2.55B	1.24	-$1.12B	$0.32	59.69
IDEXX Laboratories	$3.90B	12.65	$887.87M	$12.01	51.30

Which has more risk & volatility, NVST or IDXX?

Envista has a beta of 1.01, meaning that its share price is 1% more volatile than the S&P 500. Comparatively, IDEXX Laboratories has a beta of 1.58, meaning that its share price is 58% more volatile than the S&P 500.

Summary

IDEXX Laboratories beats Envista on 14 of the 16 factors compared between the two stocks.